ArticleCurrent opinion in biomedical engineering2021
Unconventional Biomaterials for Cardiovascular Tissue Engineering.
Article in Current opinion in biomedical engineering, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Unconventional strategies for liver tissue engineering: plant, paper, silk and nanomaterial-based scaffolds.Regenerative medicine · 2024Review
- Effect of Si Contents on the Properties of Ti15Mo7ZrxSi Alloys.Materials (Basel, Switzerland) · 2023Article
- Harnessing the potential of oxygen-generating materials and their utilization in organ-specific delivery of oxygen.Biomaterials science · 2023Review
- Oxygen-Generating Scaffolds for Cardiac Tissue Engineering Applications.ACS biomaterials science & engineering · 2023Article
- Oxygen-Generating Scaffolds: One Step Closer to the Clinical Translation of Tissue Engineered Products.Chemical engineering journal (Lausanne, Switzerland : 1996) · 2023Article
- Functional Hydrogels for Treatment of Chronic Wounds.Gels (Basel, Switzerland) · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Due to a growing demand for cardiac transplants, and dearth of available compatible organ donors, cardiovascular tissue constructs are increasingly sought to improve the quality of treatment of the patients. Biomaterials that are used to produce scaffolds for tissue engineering must overcome several challenges to achieve appropriate structure and biomimetic properties such as biocompatibility, biodegradability, and mechanical strength. The complex procedures required to manufacture biomaterials, as well as the cost associated with the production, has led to consideration of using naturally-derived unconventional biomaterials to fabricate 3D scaffolds. Due to factors such as availability, accessibility, flexibility, and low cost of the raw material, unconventional natural biomaterials such as silk, plant leaves, and paper have been evaluated for their use in cardiovascular tissue engineering. This review summarizes the use of such unconventional, naturally sourced biomaterials and their applications in cardiovascular tissue engineering.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.